Amundi Asset Management US’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $56.2M | Sell |
176,418
-26,000
| -13% | -$8.29M | 0.04% | 383 |
|
|
2020
Q4 | $65.6M | Sell |
202,418
-102,273
| -34% | -$33.2M | 0.06% | 333 |
|
|
2020
Q3 | $84.4M | Buy |
304,691
+14,704
| +5% | +$4.07M | 0.09% | 230 |
|
|
2020
Q2 | $70M | Buy |
289,987
+59,528
| +26% | +$14.4M | 0.08% | 251 |
|
|
2020
Q1 | $33.5M | Sell |
230,459
-27,026
| -10% | -$3.92M | 0.06% | 294 |
|
|
2019
Q4 | $43.9M | Sell |
257,485
-283,599
| -52% | -$48.4M | 0.05% | 347 |
|
|
2019
Q3 | $96.3M | Sell |
541,084
-215,404
| -28% | -$38.3M | 0.14% | 162 |
|
|
2019
Q2 | $197M | Buy |
756,488
+108,282
| +17% | +$28.2M | 0.16% | 136 |
|
|
2019
Q1 | $185M | Buy |
648,206
+491,750
| +314% | +$140M | 0.26% | 92 |
|
|
2018
Q4 | $50.9K | Buy |
156,456
+58,362
| +59% | +$19K | 0.05% | 252 |
|
|
2018
Q3 | $44.1M | Buy |
98,094
+4,788
| +5% | +$2.15M | 0.06% | 316 |
|
|
2018
Q2 | $38.2M | Buy |
93,306
+23,751
| +34% | +$9.72M | 0.06% | 336 |
|
|
2018
Q1 | $20.2M | Buy |
69,555
+4,527
| +7% | +$1.32M | 0.03% | 475 |
|
|
2017
Q4 | $12.2M | Buy |
+65,028
| New | +$12.2M | 0.02% | 623 |
|